Sardinian multiple sclerosis is associated with hla-dr4: A serologic and molecular analysis

Neurology

Volumn 38, Issue 11, 1988, Pages 1749-1753

  Marrosu, M G ^a   Muntoni, F ^a   Murru, M R ^a   Spinicci, G ^a   Pischedda, M P ^a   Goddi, F ^b   Cossu, P ^b   Pirastu, M ^b  

^a Azienda Ospedaliero Universitaria   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR4 ANTIGEN;

CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; DNA; FEMALE; GENETIC MARKERS; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMAN; ITALY; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUPPORT, NON-U.S. GOV'T;

EID: 0023727531     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.11.1749     Document Type: Article

References (42)

1. Cendrowski WS. Multiple sclerosis discordance in three pairs of dizygotic twins. J Med Genet 1968;5:266-271.
2. Kuweit EK. Genetical aspects of MS with special regard to histocompatibility determinants. Acta Neurol Scand Suppl 63 1977;55:23-42.
3. Horile RW, Hodge SE, Iselius L. Genetic susceptibility to multiple sclerosis. A review. Int J Epidemiol 1983;12:8-16.
4. Jersild C, Fog T. Histocompatibility (HLA) antigens associated with multiple sclerosis. Seres Immunobiol Stand 1972;18:282-286.
5. Naito S, Namerow N, Mickey MR, Tuarsaki PI. Multiple sclerosis association with HLA-A3. Tissue Antigens 1972;2:1-4.
6. Bertrams J, Kuwert EK. Association of histocompatibility haplotype HLA-A3-B7 with MS. J Immunol 1976;117:1906-1912.
7. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972;1:1240-1241.
8. Engell T, Raun NE, Thomsen M, Platz P. HLA and heterogeneity of multiple sclerosis. Neurology 1982;32:1043-1046.
9. Ryder LP, Svejgaard A. Association between HLA and disease. Report from the HLA and disease registry of Copenhagen, 1976. Published by the authors. Manyfolded by Compactas, Copenhagen.
10. Jersild C. The major histocompatibility system: HLA and multiple sclerosis. Acta Neurol Scand Suppl 63 1977;55:17-21.
11. Bertrams J. Immunogenetical aspects of MS with special regard to the HLA histocompatibility system. Boll 1st Sieroter Milan 1978;56:506-515.
12. Madigand M, Oger JJF, Fauchet R, Sabouraud O, Genetet B. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. J Neurol Sci 1982;53:519-529.
13. Lamoureux G, Duquette P, Lapierre Y, Cosgrove B, Bourret G, Labrie L. HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection. J Neurol 1983;230:91-104.
14. Salier JP, Sesbue R, Martin-Mondiere C, et al. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. J Clin Invest 1986;78:533-538.
15. Kurdi A, Ayesh I, Abdallat A, Maayta U. Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans. Lancet 1977;1:1123-1125.
16. al-Din ASN, al-Saffar M, Siboo R, Behbehani K. Association between HLA-D region epitopes and multiple sclerosis in Arabs. Tissue Antigens 1986;27:196-200.
17. Francis DA, Batchelor JR, McDonald WI, et al. Multiple sclerosis in Northeast Scotland. An association with HLA-DQwl. Brain 1987;110:181-196.
18. Brautbar C, Cohen I, Kahana E, Alter M, Jargensen F, Lamm L. Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis. Tissue Antigens 1977;10:291-302.
19. Naito S, Kuroiwa Y, Itoyama T, et al. HLA and Japanese MS. Tissue Antigens 1978;12:19-24.
20. Owerbach D, Lemmark A, Platz P, et al. HLA-D region B-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin dependent diabetic individuals. Nature 1983;303:815-817.
21. Cohen D, Le Gall I, Marcadet A, Font MP, Lalouel JM, Dausset J. Clusters of HLA class II B restriction fragments describe allelic series. Proc Natl Acad Sci USA 1984;81:7870-7874.
22. Cohen D, Cohen O, Marcadet A, et al. Class II HLA-DC B-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci USA 1984;81:1774-1778.
23. Marcadet A, Masaart C, Semana G, et al. Association of class II HLA-DQ fi-chain DNA restriction fragments with multiple sclerosis. Immunogenetics 1983;22:93-96.
24. Orelup O, Fredrikson S, Olsson T, Kam-Hansen S. HLA Class II genes in chronic progressive and in relapsing/remitting multiple sclerosis. Lancet 1987;2:327.
25. Granieri E, Rosati G. Italy: a medium- or high-risk area for multiple sclerosis? An epidemiologic study in Barbagia, Sardinia, southern Italy. Neurology 1982;32:466-472.
26. Granieri E, Rosati G, Tola R, et al. The frequency of multiple sclerosis in Mediterranean Europe: an incidence and prevalence study in Barbagia, Sardinia, insular Italy. Acta Neurol Scand 1983;68:84-90.
27. Rosati G, Aiello I, Granieri E, et al. Incidence of multiple sclerosis in Macomer, Sardinia 1912-1981: onset of the disease after 1950. Neurology 1986;36:14-19.
28. Rosati G, Aiello I, Pirastru MI, et al. Sardinia, a high-risk area for multiple sclerosis: a prevalence and incidence study in the district of Alghero. Ann Neurol 1987;21:190-194.
29. Bom P, Tavolato BF, Ballatori E, CazzuUo CL. Epidemiological survey on multiple sclerosis in Italy. Riv Patol Nerv Ment 1976;97:205-210.
30. Kurtzke JF. Geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 1980;62:65-80.
31. Rose AS, Ellison GW, Myers LM, Tourtelotte WW. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976;26(suppl):20-22.
32. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scales (EDSS). Neurology 1983;33:1444-1454.
33. Nomenclature Committee of the 9th International Congress, Histocompatibility Testing 1984.
34. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-517.
35. Mattiutz PL, Baricordi O, Conighi C, et al. HLA antigens in Italian MS patients. In: Abstracts of the 8th Histocompatibility Conference. Los Angeles, February 4th 1980.
36. Zibetti A, Cazzullo CL, Smeraldi E, Scorza-Smeraldi R. HLA typing on Italian multiple sclerosis population. Boll 1st Sierot Milan 1977;56:539-544.
37. Piazza A, Belvedere MC, Bemoco P, et al. HLA variation in four Sardinian villages under differential selective pressure by malaria. In: Dausset J, Colombani J, eds. Histocompatibility testing. Copenhagen: Munksgaard, 1972:73-88.
38. Bodmer WF. Population genetics of the HLA system: retrospect and prospect. In: Dausset J, Colombani J, eds. Histocompatibility testing. Copenhagen: Munksgaard, 1972:611-667.
39. Ebers GC, Paty DW, Stiller CR, Nelson RF, Seland TP, Larsen B. HLA-typing in multiple sclerosis sibling pairs. Lancet 1982;2:88-90.
40. Cohen D, Cohen O, Marcadet A, et al. Association of class I and class II MHC restriction fragment polymorphism with HLA-related diseases. In: Albert ED, et al, eds. Histocompatibility testing. Heidelberg: Springer-Verlag, 1984:557-558.
41. Kim SJ, Holbeck SL, Nisperos B, Hansen JA, Maeda H, Nepon GT. Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ B-chain gene. Proc Natl Acad Sci USA 1985;82:8139-8143.
42. Singal DP, Reid B, Kassman YB, D'Souza M, Bensen WG, Adachi JD. HLA-DQ B chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet 1987;2:1118-1120.